Corient Private Wealth
MEDP icon

Corient Private Wealth’s Medpace MEDP Stock Holding History

Corient Private Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.34M Buy
6,314
+4,701
+291% +$2.17M ﹤0.01% 1072
2026
Q1 		$773K Sell
1,613
-217
-12% -$111K ﹤0.01% 1790
2025
Q4 		$1.03M Buy
1,830
+120
+7% +$68.1K ﹤0.01% 1498
2025
Q3 		$879K Sell
1,710
-2,699
-61% -$1.18M ﹤0.01% 1490
2025
Q2 		$1.38M Buy
4,409
+1,415
+47% +$425K ﹤0.01% 1209
2025
Q1 		$912K Buy
2,994
+614
+26% +$207K ﹤0.01% 1315
2024
Q4 		$791K Buy
2,380
+1,101
+86% +$373K ﹤0.01% 1414
2024
Q3 		$427K Sell
1,279
-164
-11% -$62.3K ﹤0.01% 1825
2024
Q2 		$594K Buy
1,443
+507
+54% +$201K ﹤0.01% 1555
2024
Q1 		$378K Buy
936
+20
+2% +$7.03K ﹤0.01% 1773
2023
Q4 		$281K Buy
+916
New +$247K ﹤0.01% 1894

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Corient Private Wealth's MEDP Position: Q2 2026 in Review

Corient Private Wealth increased its Medpace (MEDP) stake by 291% in Q2 2026, buying an estimated $2.17M and bringing the position to 6,314 shares worth $3.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Corient Private Wealth first reported a position in MEDP in Q4 2023 and has held it in 11 quarters since. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Corient Private Wealth held 6,314 shares of Medpace worth $3.34M as of Q2 2026.
  • Corient Private Wealth bought 4,701 Medpace shares in Q2 2026, an estimated $2.17M.
  • Medpace made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1072 holding.
  • Corient Private Wealth first reported a position in Medpace in Q4 2023 and has held it in 11 quarters since.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.